TITLE

A comparison of duloxetine hydrochloride with fluoxetine hydrochloride in major depressive disorders: a pilot study

AUTHOR(S)
Sah, Ravinder Kumar; Rehan, Harmeet Singh; Unni, Kannanore Eloremadathil Sadanandan; Chopra, Deepti; Manak, Seema; Narula, Preeta Kaur
PUB. DATE
June 2010
SOURCE
Health (1949-4998);Jun2010, Vol. 2 Issue 6, p620
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
To compare remission rate, relapse rate and tolerability of duloxetine, a dual reuptake inhibitor of 5-hydroxy serotonin (5-HT) and norepinephrine (NE), versus fluoxetine, a reuptake inhibitor of 5-HT during follow up period of 16 weeks in major depressive disorder (MDD) a open label comparative trial was conducted. Trial was comprising of 60 patients, diagnosed with MDD, were allocated to fluoxetine group (n*-30, 20-60mg od) or duloxetine group (n*-30, 40-60mg od) for 16 weeks. The end points were remission and relapse assessed by Hamilton Rating scale for Depression-24 items (HAMD-24). In results the mean fall in HAMD-24 scores between groups was comparable till 4 weeks. Thereafter, at 8 weeks the mean fall in HAMD-24 score was significantly greater in duloxetine group (p value < 0.05). At 16 weeks the mean fall was highly significant (p value < 0.01) in duloxetine group. Thirty percent patients in duloxetine group achieved remission in comparison to none in fluoxetine group. None of the patient, in any group, reported relapse. Adverse effects were mild to moderate in severity.In conclusion duloxetine has a better pharmacological profile over fluoxetine in terms of efficacy and safety.
ACCESSION #
52405829

 

Related Articles

  • Bupropion: A Review of its Use in the Management of Major Depressive Disorder. Dhillon, Sohita; Yang, Lily P. H.; Curran, Monique P. // Drugs;2008, Vol. 68 Issue 5, p653 

    Bupropion is presumed to be a dopamine-norepinephrine reuptake inhibitor and is an effective antidepressant. It is available as three oral formulations: (i) bupropion immediate release (IR) [Wellbutrin] administered three times daily; (ii) bupropion sustained release (SR) [Wellbutrin SR]...

  • Intermittent and continuous swim stress-induced behavioral depression: sensitivity to norepinephrine- and serotonin-selective antidepressants. Drugan, Robert C.; Macomber, Heather; Warner, Timothy // Psychopharmacology;Oct2010, Vol. 212 Issue 1, p85 

    Intermittent swim stress (ISS) produces deficits in swim escape learning and increases immobility in the forced swim test (FST). A previous attempt to reverse this immobility with the selective serotonin reuptake inhibitor (SSRI), fluoxetine (FLX), was unsuccessful, but the sensitivity of this...

  • Sex- and age-related differences in major depressive disorder with comorbid anxiety treated with fluoxetine. Cassano, P.; Soares, C. N.; Cohen, L. S.; Lyster, A. K.; Fava, M. // Archives of Women's Mental Health;2004, Vol. 7 Issue 3, p167 

    Objective: To examine sex- and age-related differences of treatment outcome in a cohort of outpatients with major depressive disorder (MDD), with and without comorbid anxiety, treated with fluoxetine. Methods: Outpatients with a SCID-diagnosis of MDD aged 18 to 65 years were treated openly with...

  • Fluoxetine plus cognitive behavioural therapy improves symptoms of major depressive disorder in adolescents. Leon, Andrew C. // Evidence Based Mental Health;Feb2005, Vol. 8 Issue 1, p10 

    The article presents a study on the effectiveness of fluoxetine and cognitive behavioral therapy (CBT) for treating adults with major depressive disorder. Researchers observed that at 12 weeks, fluoxetine plus CBT significantly improved symptoms of depression compared with placebo in adolescents...

  • Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response. Wenjiao Min; Tao Li; Xiaohong Ma; Zhengyu Li; Tao Yu; Dong Gao; Bo Zhang; Yang Yun; Xueli Sun // Psychopharmacology;Aug2009, Vol. 205 Issue 3, p409 

    Serotonin transporter (5-HTT) and norepinephrine transporter (NET) are the primary targets of many antidepressants. We aimed to determine the potential correlations of 5-HTT/NET gene polymorphisms with the susceptibility to depression and the antidepressant response to selective serotonin...

  • Escitalopram: A Pharmacoeconomic Review of its Use in Depression. Croom, Katherine F.; Plosker, Greg L. // PharmacoEconomics;2003, Vol. 21 Issue 16, p1185 

    Escitalopram (Cipralex[sup ®]), a new highly selective serotonin reuptake inhibitor (SSRI), is the active S-enantiomer of RS-citalopram. It is effective in the treatment of patients with major depressive disorder (MDD) and may have a faster onset of therapeutic effect than citalopram. It has...

  • ACP treatment guideline for antidepressants. Elliott, William T. // Clinical Cardiology Alert;Jan2009 Pharmacology, p2 

    The article deals with the practice guideline issued by the American College of Physicians in January 2009 concerning the use of antidepressants to treat depressive disorders. Particular focus is given on second-generation antidepressants like selective serotonin reuptake inhibitors (SSRI)...

  • Fluoxetine effect on kidney water reabsorption. Zenaide Providello Moyses; Fausto Kigui Nakandakari; Antonio José Magaldi // Nephrology Dialysis Transplantation;Apr2008, Vol. 23 Issue 4, p1173 

    Background. The pathogenesis of hyponatraemia caused by fluoxetine(Fx) use in the treatment of depression is not well understood. It has been attributed to a SIADH, although ADH-enhanced plasma level has not yet been demonstrated in all the cases reported in humans. This experiment aimed at...

  • The effect of grape seed hydroalcholic extract on testosterone concentration in fluoxetine induced oxidative stress in the mouse testise. Hajizadeh, Z.; Soleimani, M.; Najafi, B.; Zarei, L. // Iranian Journal of Reproductive Medicine;Jun2014 Supplement, Vol. 12, p110 

    Introduction: The selective serotonin reuptake inhibitors (SSRI), including fluoxetine (FLX) are used for the treatment of depression and psychiatric disorders such as panic disorder and anxiety. Grape seed extract (GS extract) is a natural extract from the seed of grape that is rich in mono-,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics